RAPGEF3 and brain ischemia: Moreover, Epac-1/Rap-1 signaling has been implicated in microglial function and phenotype switching, suggesting it may serve as a novel therapeutic target in cerebral ischemia–reperfusion injury (Sun et al., 2023; Pan et al., 2022).